抗排异的药物会增加癌症复发的可能性。
the anti-rejection drugs can increase the odds of cancer recurrence.
病人还得克服长久的组织排异反应，终生需要服用抗排异反应药物。
And the patient must overcome the always-present risk of tissue rejection, for which she will require immunosuppressant drugs for the rest of her life.
换肾成功以后，病人需要终生服用抗排异药物，这也是一笔巨大的费用。
After successful kidney transplant, the patient has to take anti-rejection drugs during the rest of his life, which also means a great amount of expense.
应用推荐